FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 331:81-84 July 14, 1994 Number 2 Next

	Full Text Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Diabetes and pancreatic cancer are known to be associated, but the cause of the association and whether diabetes is a risk factor for pancreatic cancer remain controversial.

Methods A total of 720 patients with pancreatic cancer and 720 control patients from 14 Italian centers were enrolled in the study. All subjects were interviewed personally and in detail about their clinical history. The diagnosis of diabetes was based on criteria recommended by the American Diabetes Association.

Results One hundred sixty-four patients with pancreatic cancer (22.8 percent) and 60 controls (8.3 percent) had diabetes. In the majority of the patients with pancreatic cancer (56.1 percent), diabetes was diagnosed either concomitantly with the cancer (in 40.2 percent), or within two years before the diagnosis of cancer (in 15.9 percent). The association between the two conditions was significant (odds ratio, 3.04; 95 percent confidence interval, 2.21 to 4.17). However, when only patients with diabetes of three or more years' duration were considered, the association was no longer significant (odds ratio, 1.43; 95 percent confidence interval, 0.98 to 2.07). All the patients with pancreatic cancer whose diabetes had been diagnosed before the cancer had non-insulin-dependent diabetes; all but one of the control patients with diabetes had the non-insulin-dependent form of the disease.

Conclusions Diabetes in patients with pancreatic cancer is frequently of recent onset and is presumably caused by the tumor. Diabetes is not a risk factor for pancreatic cancer.

Source Information

From the Institute of Medicine and Gastroenterology, University of Bologna, St. Orsola Hospital, Bologna, Italy. The members of the Italian Pancreatic Cancer Study Group include Patrizia Priori, M.D., Orazio Campione, M.D., Riccardo Casadei, M.D., Maria Brambati, M.D., Carlo Lesi, M.D., and Antonio Frena, M.D. (Bologna); Alberto Malesci, M.D., and Alessandro Zerbi, M.D. (Milan); Angelo Andriulli, M.D., and Patrizio Acquadro, M.D. (Turin); Alessandro D'Ambrosi, M.D., and Vittorio Alvisi, M.D. (Ferrara); Giuseppe Montalto, M.D., and Antonio Carroccio, M.D. (Palermo); Valerio De Conca, M.D., Alberto Mornese, M.D., and Carlo Mansi, M.D. (Genoa); Carlo Battistini, M.D. (Parma); Cosimo Sperti, M.D., and Claudio Pasquali, M.D. (Padua); Luigi Gaeta, M.D., and Mario Mazzeo, M.D. (Naples); and Martina Felder, M.D. (Bolzano).

Address reprint requests to Professor Gullo at the Istituto di Clinica Medica e Gastroenterologia, Ospedale S. Orsola, Via Massarenti, 9, 40138 Bologna, Italy.

Full Text of this Article

Related Letters:

Pancreatic Cancer and Diabetes
Balkau B., Barrett-Connor E., Eschwege E., Jones S.C., Alberti K.G.M.M., O'Shea R. S., Strom B. L., Berlin J. A., Gullo L., Pezzilli R., Morselli-Labate A. M.
Extract | Full Text  
N Engl J Med 1994; 331:1526-1528, Dec 1, 1994. Correspondence

This article has been cited by other articles:

• Erbel, S., Reers, C., Eckstein, V. W., Kleeff, J., Buchler, M. W., Nawroth, P. P., Ritzel, R. A. (2008). Proliferation of Colo-357 Pancreatic Carcinoma Cells and Survival of Patients With Pancreatic Carcinoma Are Not Altered by Insulin Glargine. Diabetes Care 31: 1105-1111 [Abstract] [Full Text]  
• Brand, R. E, Lerch, M. M, Rubinstein, W. S, Neoptolemos, J. P, Whitcomb, D. C, Hruban, R. H, Brentnall, T. A, Lynch, H. T, Canto, M. I, Participants of the Fourth International Symposium, (2007). Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut 56: 1460-1469 [Abstract] [Full Text]  
• Inoue, M., Iwasaki, M., Otani, T., Sasazuki, S., Noda, M., Tsugane, S., for the Japan Public Health Center-Based Prospecti, (2006). Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan.. Arch Intern Med 166: 1871-1877 [Abstract] [Full Text]  
• Wang, F., Gupta, S., Holly, E. A. (2006). Diabetes mellitus and pancreatic cancer in a population-based case-control study in the san francisco bay area, california.. Cancer Epidemiol. Biomarkers Prev. 15: 1458-1463 [Abstract] [Full Text]  
• Pancreatic Section, (2005). Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas. Gut 54: v1-v16 [Full Text]  
• Delgado-Rodriguez, M, Llorca, J (2004). Bias. J. Epidemiol. Community Health 58: 635-641 [Abstract] [Full Text]  
• Basso, D, Millino, C, Greco, E, Romualdi, C, Fogar, P, Valerio, A, Bellin, M, Zambon, C-F, Navaglia, F, Dussini, N, Avogaro, A, Pedrazzoli, S, Lanfranchi, G, Plebani, M (2004). Altered glucose metabolism and proteolysis in pancreatic cancer cell conditioned myoblasts: searching for a gene expression pattern with a microarray analysis of 5000 skeletal muscle genes. Gut 53: 1159-1166 [Abstract] [Full Text]  
• Ghiorzo, P., Pastorino, L., Bonelli, L., Cusano, R., Nicora, A., Zupo, S., Queirolo, P., Sertoli, M., Pugliese, V., Bianchi-Scarra, G. (2004). INK4/ARF germline alterations in pancreatic cancer patients. Ann Oncol 15: 70-78 [Abstract] [Full Text]  
• Furukawa, H. (2002). Diagnostic Clues for Early Pancreatic Cancer. Jpn J Clin Oncol 32: 391-392 [Full Text]  
• Hart, A. R (1999). Classic diseases revisited: Pancreatic cancer: any prospects for prevention?. Postgrad. Med. J. 75: 521-526 [Abstract] [Full Text]  
• Balkau, B., Barrett-Connor, E., Eschwege, E., Jones, S.C., Alberti, K.G.M.M., O'Shea, R. S., Strom, B. L., Berlin, J. A., Gullo, L., Pezzilli, R., Morselli-Labate, A. M. (1994). Pancreatic Cancer and Diabetes. NEJM 331: 1526-1528 [Full Text]